Reported: Generic drug price-fixing conspiracy GENRX (Other)
Compiled by ScamMarketCap from public recordsHappened Sep 22, 2026United States
Since 2016, a coalition of state attorneys general has alleged that dozens of generic drug manufacturers and executives colluded to fix prices, avoid competition and rig bids on more than 100 generic drugs. Some coordinated price increases exceeded 1,000 percent, and the price of digoxin made by Heritage tripled. The states filed complaints in 2016, 2019 and 2020, and a fourth complaint filed in 2026 names Novartis and Sandoz.
The states have settled with Glenmark, Lannett, Bausch, Apotex, Heritage and Heritage's parent company, Emcure, for about $96.5 million. In September 2026, the U.S. District Court for the District of Connecticut preliminarily approved a plan by California and 47 other states and territories to distribute the money, and New York said tens of millions of dollars will go to consumers who overpaid.
The claims process covers consumers who bought an eligible generic drug between May 2009 and December 2019. The deadline to file at AGGenericDrugs.com is March 8, 2027.
This case file is compiled from public records and established reporting. Status as of the last update, Nov 3, 2026.
Case files summarize court records, regulator actions and established reporting.
Did this happen to you too? Share what you know: dates, amounts, names used, websites and wallet addresses.
to comment. It takes one email.
Case files summarize court records, regulator actions and established reporting.
Sign in to add yourself. Only the totals are public.
Comments
Did this happen to you too? Share what you know: dates, amounts, names used, websites and wallet addresses.